LINC01117 and breast carcinoma: Because miRNA-1246 overlaps an intron of LINC01117 (ENST00000652995.1), it is hard to predict how the decreased level of spliceosomal mir-1246 in breast cancer cells [5] might affect the level of LINC01117 in breast cancer compared to normal cells, and further studies are required to resolve that.